Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAICoDis
2016-003521-42Phase 4Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of argatroban in coronary arteriosclerosis and angina pectoris, sponsored by Mitsubishi Tanabe Pharma Corporation. Started Nov 2016; status: completed.
02
Drugs
argatroban
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on 2016-003521-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003521-42.